NCT06592053

Brief Summary

Chronic post-mastectomy pain (CPMP) is a significant issue affecting many women after mastectomy. Factors like age, treatment type, and pre-surgery pain can increase the risk of developing this condition. By evaluating these factors, CPMP can be prevented more successfully and treatment strategies can be developed. This study aims to investigate the factors contributing to CPMP and contribute to the existing literature on this important topic.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
6mo left

Started Sep 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
Sep 2024Oct 2026

First Submitted

Initial submission to the registry

September 9, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
6 days until next milestone

Study Start

First participant enrolled

September 25, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2026

Last Updated

February 4, 2025

Status Verified

January 1, 2025

Enrollment Period

1.9 years

First QC Date

September 9, 2024

Last Update Submit

January 31, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Self-leeds assessment of neuropathic symptoms and sign findings in 3rd months.

    Patients; self-Leeds assessment of neuropathic symptoms and sign (S-LANSS) findings will be evaluated in the 3rd postoperative month. Patients with an S-LANSS score of 12 and above will be diagnosed with chronic neuropathic pain. In this scoring, the patient can get at least 0 points. He can get a maximum of 24 points. If the patient's score is 12 or above, the possibility of neuropathic pain is considered high.

    Postoperative 3rd month

Secondary Outcomes (4)

  • Short Form 12 questionnaire in the 3rd month

    Postoperative 3rd month

  • Short Form 12 questionnaire in the 6th month

    Postoperative 6th month

  • Self-leeds assessment of neuropathic symptoms and sign findings at 6th months

    Postoperative 6th month

  • Acute pain score

    Up to 24 hours after the operation

Interventions

Factors affecting the occurrence of chronic pain in patients undergoing elective mastectomy surgery will be investigated.

Also known as: Breast Cancer Surgery Chronic Pain

Eligibility Criteria

Age18 Years - 80 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients aged 18-80 years, with an ASA classification of I-II-III and a body mass index (BMI) between 18-35 kg/m², who will undergo mastectomy surgery or mastectomy with axillary dissection, will be included in our study.

You may qualify if:

  • Between the ages of 18-80
  • BMI 18-35 kg/m2
  • ASA (American Society of Anesthesiologists) Scoring I-II-III
  • Elective mastectomy surgery
  • Elective mastectomy and axillary dissection surgery
  • Patients who will undergo general anesthesia
  • Patients who agree to participate in the study and sign a form

You may not qualify if:

  • Patients under 18 and over 80 years of age
  • Patients who do not want to participate in the study
  • Patients with chronic pain or chronic opioid use
  • Patients with alcohol, substance or drug addiction
  • Patients with a history of previous mastectomy
  • Patients with limited cooperation such as dementia, psychiatric disorders
  • Pregnant and breastfeeding patients will be excluded from the study
  • Patients who cannot communicate in their native language will be excluded from the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Etlik City Hospital

Ankara, Yenimahalle, 06100, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Chronic PainAcute Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Musa ZENGİN, Associate Professor

    Ankara Etlik City Hospital

    STUDY DIRECTOR

Central Study Contacts

Berkant DEMİRAY, M.D.

CONTACT

Musa ZENGİN, Associate Professor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 9, 2024

First Posted

September 19, 2024

Study Start

September 25, 2024

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

October 30, 2026

Last Updated

February 4, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations